| Year |
Citation |
Score |
| 2021 |
Kanvinde PP, Malla AP, Connolly NP, Szulzewsky F, Anastasiadis P, Ames HM, Kim AJ, Winkles JA, Holland EC, Woodworth GF. Leveraging the replication-competent avian-like sarcoma virus/tumor virus receptor-A system for modeling human gliomas. Glia. PMID 33638562 DOI: 10.1002/glia.23984 |
0.319 |
|
| 2020 |
Alexander J, LaPlant QC, Pattwell SS, Szulzewsky F, Cimino PJ, Caruso FP, Pugliese P, Chen Z, Chardon F, Hill AJ, Spurrell C, Ahrendsen D, Pietras A, Starita LM, Hambardzumyan D, ... ... Holland EC, et al. Multimodal single-cell analysis reveals distinct radioresistant stem-like and progenitor cell populations in murine glioma. Glia. PMID 32621641 DOI: 10.1002/Glia.23866 |
0.318 |
|
| 2020 |
Huang M, Zhang D, Wu JY, Xing K, Yeo E, Li C, Zhang L, Holland E, Yao L, Qin L, Binder ZA, O'Rourke DM, Brem S, Koumenis C, Gong Y, et al. Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastoma. Science Translational Medicine. 12. PMID 32102932 DOI: 10.1126/Scitranslmed.Aay7522 |
0.301 |
|
| 2020 |
Horne E, Vicente Ruiz JJ, Cimino P, Jung E, Xu C, Diaz P, Hamel E, Kumasaka DK, Wagenbach MJ, Winkler F, Wordeman LG, Holland E, Stella N. EXTH-53. A BRAIN-PENETRANT MICROTUBULE-TARGETING AGENT THAT DISRUPTS HALLMARKS OF GLIOMA TUMORIGENESIS Neuro-Oncology. 22: ii98-ii99. DOI: 10.1093/neuonc/noaa215.407 |
0.308 |
|
| 2019 |
Kaffes I, Szulzewsky F, Chen Z, Herting CJ, Gabanic B, Velázquez Vega JE, Shelton J, Switchenko JM, Ross JL, McSwain LF, Huse JT, Westermark B, Nelander S, Forsberg-Nilsson K, Uhrbom L, ... ... Holland EC, et al. Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors. Oncoimmunology. 8: e1655360. PMID 31646100 DOI: 10.1080/2162402X.2019.1655360 |
0.34 |
|
| 2019 |
Wirsching HG, Zhang H, Szulzewsky F, Arora S, Grandi P, Cimino PJ, Amankulor N, Campbell JS, McFerrin L, Pattwell SS, Ene C, Hicks A, Ball M, Yan J, Zhang J, ... ... Holland EC, et al. Arming oHSV with ULBP3 drives abscopal immunity in lymphocyte-depleted glioblastoma. Jci Insight. 4. PMID 31292299 DOI: 10.1172/Jci.Insight.128217 |
0.307 |
|
| 2019 |
Horne E, Xu C, Vicente J, Cimino PJ, Wagenbach M, Hamel E, Gussio R, Diaz P, Uhlenbruck B, Deckwerth T, Wordeman L, Holland E, Stella N. DDIS-29. BRAIN-PENETRANT MICROTUBULE-TARGETING AGENT, ST-401, KILLS GLIOBLASTOMA THROUGH A NOVEL MECHANISM Neuro-Oncology. 21: vi69-vi69. DOI: 10.1093/Neuonc/Noz175.280 |
0.303 |
|
| 2018 |
Wallmann T, Zhang XM, Wallerius M, Bolin S, Joly AL, Sobocki C, Leiss L, Jiang Y, Bergh J, Holland EC, Enger PØ, Andersson J, Swartling FJ, Miletic H, Uhrbom L, et al. Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity. Iscience. 9: 71-83. PMID 30384135 DOI: 10.1016/J.Isci.2018.10.011 |
0.314 |
|
| 2018 |
Zhang F, Stephan SB, Ene CI, Smith TT, Holland EC, Stephan MT. Nanoparticles that reshape the tumor milieu create a therapeutic window for effective T cell therapy in solid malignancies. Cancer Research. PMID 29760047 DOI: 10.1158/0008-5472.CAN-18-0306 |
0.314 |
|
| 2018 |
Connolly NP, Shetty AC, Stokum JA, Hoeschele I, Siegel MB, Miller CR, Kim AJ, Ho CY, Davila E, Simard JM, Devine SE, Rossmeisl JH, Holland EC, Winkles JA, Woodworth GF. Cross-species transcriptional analysis reveals conserved and host-specific neoplastic processes in mammalian glioma. Scientific Reports. 8: 1180. PMID 29352201 DOI: 10.1038/S41598-018-19451-6 |
0.348 |
|
| 2017 |
Huang Y, Rajappa P, Hu W, Hoffman C, Cisse B, Kim JH, Gorge E, Yanowitch R, Cope W, Vartanian E, Xu R, Zhang T, Pisapia D, Xiang J, Huse J, ... ... Holland E, et al. A proangiogenic signaling axis in myeloid cells promotes malignant progression of glioma. The Journal of Clinical Investigation. PMID 28394259 DOI: 10.1172/Jci86443 |
0.358 |
|
| 2017 |
Connolly NP, Stokum JA, Schneider CS, Ozawa T, Xu S, Galisteo R, Castellani RJ, Kim AJ, Simard JM, Winkles JA, Holland EC, Woodworth GF. Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer. Plos One. 12: e0174557. PMID 28358926 DOI: 10.1371/Journal.Pone.0174557 |
0.369 |
|
| 2016 |
Gammoh N, Fraser J, Puente C, Syred HM, Kang H, Ozawa T, Lam D, Acosta JC, Finch AJ, Holland E, Jiang X. Suppression of autophagy impedes glioblastoma development and induces senescence. Autophagy. 0. PMID 27304681 DOI: 10.1080/15548627.2016.1190053 |
0.328 |
|
| 2016 |
Lu F, Chen Y, Zhao C, Wang H, He D, Xu L, Wang J, He X, Deng Y, Lu EE, Liu X, Verma R, Bu H, Drissi R, Fouladi M, ... ... Holland EC, et al. Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant Glioma. Cancer Cell. 29: 669-83. PMID 27165742 DOI: 10.1016/J.Ccell.2016.03.027 |
0.328 |
|
| 2015 |
Ene CI, Holland EC. Personalized medicine for gliomas. Surgical Neurology International. 6: S89-95. PMID 25722938 DOI: 10.4103/2152-7806.151351 |
0.321 |
|
| 2015 |
Pattwell S, Ozawa T, Juric-Sekhar G, Holland E. PTPS-23A NOVEL ROLE FOR NEUROTROPHIN SIGNALING IN PEDIATRIC ATYPICAL TERATOID RHABDOID TUMORS Neuro-Oncology. 17: v184.2-v184. DOI: 10.1093/Neuonc/Nov228.23 |
0.362 |
|
| 2014 |
Lindberg N, Jiang Y, Xie Y, Bolouri H, Kastemar M, Olofsson T, Holland EC, Uhrbom L. Oncogenic signaling is dominant to cell of origin and dictates astrocytic or oligodendroglial tumor development from oligodendrocyte precursor cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 14644-51. PMID 25355217 DOI: 10.1523/JNEUROSCI.2977-14.2014 |
0.369 |
|
| 2014 |
Kim Y, Lindberg N, Bolouri H, Delrow J, Ozawa T, Holland E. Abstract LB-27: Develop mutant isocitrate dehydrogenase 1 (IDH1)-expressing gliomas using RCAS/tv-a technology Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-27 |
0.314 |
|
| 2014 |
Ozawa T, Ellison D, Gilbertson R, Holland E. PM-15C11orf95-RELA FUSION ALONE IS SUFFICIENT TO FORM HUMAN SUPRATENTORIAL EPENDYMOMA-LIKE TUMOR IN MICE Neuro-Oncology. 16. DOI: 10.1093/Neuonc/Nou268.15 |
0.346 |
|
| 2012 |
Helmy K, Halliday J, Fomchenko E, Setty M, Pitter K, Hafemeister C, Holland EC. Identification of Global Alteration of Translational Regulation in Glioma In Vivo Plos One. 7. PMID 23056544 DOI: 10.1371/journal.pone.0046965 |
0.306 |
|
| 2012 |
Squatrito M, Vanoli F, Schultz N, Jasin M, Holland EC. 53BP1 is a haploinsufficient tumor suppressor and protects cells from radiation response in glioma Cancer Research. 72: 5250-5260. PMID 22915756 DOI: 10.1158/0008-5472.Can-12-0045 |
0.301 |
|
| 2012 |
Dougherty JD, Fomchenko EI, Akuffo AA, Schmidt E, Helmy KY, Bazzoli E, Brennan CW, Holland EC, Milosevic A. Candidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma. Cancer Research. 72: 4856-68. PMID 22865458 DOI: 10.1158/0008-5472.Can-11-2632 |
0.352 |
|
| 2012 |
Katz AM, Amankulor NM, Pitter K, Helmy K, Squatrito M, Holland EC. Astrocyte-specific expression patterns associated with the PDGF-induced glioma microenvironment. Plos One. 7: e32453. PMID 22393407 DOI: 10.1371/journal.pone.0032453 |
0.329 |
|
| 2012 |
Charles NA, Holland EC, Gilbertson R, Glass R, Kettenmann H. The brain tumor microenvironment. Glia. 60: 502-14. PMID 22379614 DOI: 10.1002/Glia.21264 |
0.353 |
|
| 2012 |
Hofstetter CP, Burkhardt JK, Shin BJ, Gürsel DB, Mubita L, Gorrepati R, Brennan C, Holland EC, Boockvar JA. Protein phosphatase 2A mediates dormancy of glioblastoma multiforme-derived tumor stem-like cells during hypoxia Plos One. 7. PMID 22253878 DOI: 10.1371/journal.pone.0030059 |
0.303 |
|
| 2012 |
Jones TS, Holland EC. Standard of care therapy for malignant glioma and its effect on tumor and stromal cells. Oncogene. 31: 1995-2006. PMID 21909136 DOI: 10.1038/onc.2011.398 |
0.341 |
|
| 2012 |
Carbajal E, Holland EC. Mouse models in preclinical drug development: Applications to cns models Genetically Engineered Mice For Cancer Research: Design, Analysis, Pathways, Validation and Pre-Clinical Testing. 549-567. DOI: 10.1007/978-0-387-69805-2_26 |
0.32 |
|
| 2011 |
Fomchenko EI, Dougherty JD, Helmy KY, Katz AM, Pietras A, Brennan C, Huse JT, Milosevic A, Holland EC. Recruited cells can become transformed and overtake PDGF-induced murine gliomas in vivo during tumor progression. Plos One. 6: e20605. PMID 21754979 DOI: 10.1371/Journal.Pone.0020605 |
0.346 |
|
| 2011 |
Charles NA, Holland EC, Gilbertson R, Glass R, Kettenmann H. The brain tumor microenvironment. Glia. 59: 1169-80. PMID 21446047 DOI: 10.1002/glia.21136 |
0.352 |
|
| 2011 |
Jones TS, Holland EC. Molecular pathogenesis of malignant glial tumors. Toxicologic Pathology. 39: 158-66. PMID 21078918 DOI: 10.1177/0192623310387617 |
0.358 |
|
| 2010 |
Squatrito M, Brennan CW, Helmy K, Huse JT, Petrini JH, Holland EC. Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas. Cancer Cell. 18: 619-29. PMID 21156285 DOI: 10.1016/j.ccr.2010.10.034 |
0.309 |
|
| 2010 |
Charles N, Holland EC. The perivascular niche microenvironment in brain tumor progression Cell Cycle. 9: 3012-3021. PMID 20714216 DOI: 10.4161/cc.9.15.12710 |
0.349 |
|
| 2010 |
Charles N, Ozawa T, Squatrito M, Bleau AM, Brennan CW, Hambardzumyan D, Holland EC. Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell. 6: 141-52. PMID 20144787 DOI: 10.1016/j.stem.2010.01.001 |
0.357 |
|
| 2010 |
Benezra M, Hambardzumyan D, Penate-Medina O, Veach DR, Pillarsetty N, Smith-Jones P, Zanzonico P, Longo VA, Holland EC, Larson SM, Bradbury MS. Abstract LB-299: F-dasatinib inhibits glioma cell proliferation and alters expression of PDGFR signaling pathway intermediates in PDGFR-overexpressing glioma models Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-299 |
0.3 |
|
| 2009 |
Momota H, Holland EC. Mouse models of CNS embryonal tumors Brain Tumor Pathology. 26: 43-50. PMID 19856214 DOI: 10.1007/s10014-009-0253-0 |
0.349 |
|
| 2009 |
Bleau AM, Huse JT, Holland EC. The ABCG2 resistance network of glioblastoma. Cell Cycle (Georgetown, Tex.). 8: 2936-44. PMID 19713741 |
0.347 |
|
| 2008 |
Hambardzumyan D, Squatrito M, Carbajal E, Holland EC. Glioma formation, cancer stem cells, and Akt signaling Stem Cell Reviews. 4: 203-210. PMID 18595010 DOI: 10.1007/s12015-008-9021-5 |
0.307 |
|
| 2008 |
Hambardzumyan D, Becher OJ, Holland EC. Cancer stem cells and survival pathways Cell Cycle. 7: 1371-1378. PMID 18421251 |
0.368 |
|
| 2008 |
Becher OJ, Hambardzumyan D, Fomchenko EI, Momota H, Mainwaring L, Bleau AM, Katz AM, Edgar M, Kenney AM, Cordon-Cardo C, Blasberg RG, Holland EC. Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas. Cancer Research. 68: 2241-9. PMID 18381430 DOI: 10.1158/0008-5472.Can-07-6350 |
0.346 |
|
| 2008 |
Bleau AM, Howard BM, Taylor LA, Gursel D, Greenfield JP, Lim Tung HY, Holland EC, Boockvar JA. New strategy for the analysis of phenotypic marker antigens in brain tumor-derived neurospheres in mice and humans. Neurosurgical Focus. 24: E28. PMID 18341405 DOI: 10.3171/FOC/2008/24/3-4/E27 |
0.344 |
|
| 2008 |
Hambardzumyan D, Becher OJ, Rosenblum MK, Pandolfi PP, Manova-Todorova K, Holland EC. PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes & Development. 22: 436-48. PMID 18281460 DOI: 10.1101/Gad.1627008 |
0.306 |
|
| 2007 |
Liu Y, Yeh N, Zhu XH, Leversha M, Cordon-Cardo C, Ghossein R, Singh B, Holland E, Koff A. Somatic cell type specific gene transfer reveals a tumor-promoting function for p21(Waf1/Cip1). The Embo Journal. 26: 4683-93. PMID 17948060 DOI: 10.1038/Sj.Emboj.7601886 |
0.335 |
|
| 2007 |
Tchougounova E, Kastemar M, Bråsäter D, Holland EC, Westermark B, Uhrbom L. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma Oncogene. 26: 6289-6296. PMID 17438529 DOI: 10.1038/sj.onc.1210455 |
0.352 |
|
| 2007 |
Fomchenko EI, Holland EC. Platelet-Derived Growth Factor-Mediated Gliomagenesis and Brain Tumor Recruitment Neurosurgery Clinics of North America. 18: 39-58. PMID 17244553 DOI: 10.1016/j.nec.2006.10.006 |
0.378 |
|
| 2007 |
Hambardzumyan D, Lyustikman Y, Holland EC. An update on mouse brain tumor models in cancer drug discovery Expert Opinion On Drug Discovery. 2: 1435-1451. DOI: 10.1517/17460441.2.11.1435 |
0.319 |
|
| 2006 |
Shih AH, Holland EC. Notch signaling enhances nestin expression in gliomas Neoplasia. 8: 1072-1082. PMID 17217625 DOI: 10.1593/neo.06526 |
0.324 |
|
| 2006 |
Hambardzumyan D, Squartro M, Holland EC. Radiation resistance and stem-like cells in brain tumors Cancer Cell. 10: 454-456. PMID 17157785 DOI: 10.1016/j.ccr.2006.11.008 |
0.303 |
|
| 2006 |
Fomchenko EI, Holland EC. Mouse models of brain tumors and their applications in preclinical trials Clinical Cancer Research. 12: 5288-5297. PMID 17000661 DOI: 10.1158/1078-0432.CCR-06-0438 |
0.369 |
|
| 2006 |
Shih AH, Holland EC. Platelet-derived growth factor (PDGF) and glial tumorigenesis Cancer Letters. 232: 139-147. PMID 16139423 DOI: 10.1016/j.canlet.2005.02.002 |
0.324 |
|
| 2005 |
Momota H, Holland EC. Bioluminescence technology for imaging cell proliferation Current Opinion in Biotechnology. 16: 681-686. PMID 16263256 DOI: 10.1016/j.copbio.2005.10.012 |
0.318 |
|
| 2005 |
Hu X, Holland EC. Applications of mouse glioma models in preclinical trials. Mutation Research. 576: 54-65. PMID 16011838 DOI: 10.1016/j.mrfmmm.2004.08.023 |
0.358 |
|
| 2005 |
Hu X, Pandolfi PP, Li Y, Koutcher JA, Rosenblum M, Holland EC. mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma. Neoplasia (New York, N.Y.). 7: 356-68. PMID 15967113 DOI: 10.1593/Neo.04595 |
0.325 |
|
| 2005 |
Fomchenko EI, Holland EC. Stem cells and brain cancer Experimental Cell Research. 306: 323-329. PMID 15925587 DOI: 10.1016/j.yexcr.2005.03.007 |
0.346 |
|
| 2005 |
Uhrbom L, Kastemar M, Johansson FK, Westermark B, Holland EC. Cell type-specific tumor suppression by Ink4a and Arf in kras-induced mouse gliomagenesis Cancer Research. 65: 2065-2069. PMID 15781613 DOI: 10.1158/0008-5472.CAN-04-3588 |
0.356 |
|
| 2004 |
Shih AH, Holland EC. Developmental neurobiology and the origin of brain tumors Journal of Neuro-Oncology. 70: 125-136. PMID 15674474 DOI: 10.1007/s11060-004-2746-3 |
0.343 |
|
| 2004 |
Uhrbom L, Nerio E, Holland EC. Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model Nature Medicine. 10: 1257-1260. PMID 15502845 DOI: 10.1038/nm1120 |
0.309 |
|
| 2004 |
Shih AH, Dai C, Hu X, Rosenblum MK, Koutcher JA, Holland EC. Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis. Cancer Research. 64: 4783-9. PMID 15256447 DOI: 10.1158/0008-5472.CAN-03-3831 |
0.326 |
|
| 2003 |
Hesselager G, Holland EC, Rutka JT, Parsa AT. Using mice to decipher the molecular genetics of brain tumors Neurosurgery. 53: 685-695. PMID 12943584 |
0.339 |
|
| 2002 |
Weiss WA, Israel M, Cobbs C, Holland E, James CD, Louis DN, Marks C, McClatchey AI, Roberts T, Van Dyke T, Wetmore C, Chiu IM, Giovannini M, Guha A, Higgins RJ, et al. Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum. Oncogene. 21: 7453-63. PMID 12386807 DOI: 10.1038/Sj.Onc.1205936 |
0.33 |
|
| 2002 |
Begemann M, Fuller GN, Holland EC. Genetic modeling of glioma formation in mice. Brain Pathology (Zurich, Switzerland). 12: 117-32. PMID 11770894 |
0.325 |
|
| 2001 |
Holland EC. Progenitor cells and glioma formation Current Opinion in Neurology. 14: 683-688. PMID 11723374 DOI: 10.1097/00019052-200112000-00002 |
0.327 |
|
| 2001 |
Uhrbom L, Holland EC. Modeling gliomagenesis with somatic cell gene transfer using retroviral vectors Journal of Neuro-Oncology. 53: 297-305. PMID 11718262 DOI: 10.1023/A:1012208314436 |
0.328 |
|
| 2001 |
Louis DN, Holland EC, Cairncross JG. Glioma classification: a molecular reappraisal. The American Journal of Pathology. 159: 779-86. PMID 11549567 DOI: 10.1016/S0002-9440(10)61750-6 |
0.324 |
|
| 2001 |
Holland EC. Brain tumor animal models: Importance and progress Current Opinion in Oncology. 13: 143-147. PMID 11307055 DOI: 10.1097/00001622-200105000-00002 |
0.346 |
|
| 2000 |
Caskey LS, Fuller GN, Bruner JM, Yung WK, Sawaya RE, Holland EC, Zhang W. Toward a molecular classification of the gliomas: histopathology, molecular genetics, and gene expression profiling. Histology and Histopathology. 15: 971-81. PMID 10963139 DOI: 10.14670/Hh-15.971 |
0.313 |
|
| Show low-probability matches. |